These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7459048)

  • 41. Modeling and Monte Carlo simulations in oral drug absorption.
    Dokoumetzidis A; Kosmidis K; Argyrakis P; Macheras P
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):200-5. PubMed ID: 15733215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
    Verma S; Gokhale R; Burgess DJ
    Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen.
    Yiyun C; Tongwen X; Rongqiang F
    Eur J Med Chem; 2005 Dec; 40(12):1390-3. PubMed ID: 16226353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving flow properties of ibuprofen by fluidized bed particle thin-coating.
    Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J
    Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies on the oral absorption of ibuprofen guaiacol-ester in man.
    Catanese B; Barillari G; Iorio E; Pini L
    Boll Chim Farm; 1982 Nov; 121(11):567-72. PubMed ID: 7183325
    [No Abstract]   [Full Text] [Related]  

  • 46. Enantioselective inhibition of the binding of rac-profens to human serum albumin induced by lithocholate.
    Bertucci C
    Chirality; 2001 Jul; 13(7):372-8. PubMed ID: 11400191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of N4-acetylsulfadimethoxine to the interaction of sulfadimethoxine with ketoprofen in rabbits.
    Imamura Y; Mori H; Otagiri M
    Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1299-303. PubMed ID: 3607955
    [No Abstract]   [Full Text] [Related]  

  • 48. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions of anti-inflammatory 2-arylpropionates (profens) with the metabolism of fatty acids: in vitro studies.
    Mayer JM; Roy-De Vos M; Audergon C; Testa B; Etter JC
    Int J Tissue React; 1994; 16(2):59-72. PubMed ID: 7960502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binding constant determination of drugs toward subdomain IIIA of human serum albumin by near-infrared dye-displacement capillary electrophoresis.
    Sowell J; Mason JC; Strekowski L; Patonay G
    Electrophoresis; 2001 Aug; 22(12):2512-7. PubMed ID: 11519955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro release of ketoprofren and ibuprofen from viscoelastic gels.
    Bajardi M; Pitarresi G; Roccaro A; Giammona G; Palazzo S
    Boll Chim Farm; 1995 Jun; 134(6):312-5. PubMed ID: 7546537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption.
    Bergström CA
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):156-61. PubMed ID: 15733209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Correlations between the absorption of ibuprofen guaiacol ether and its behavior in the presence of blood or gastric juice].
    Interdomato N; Catanese B; de Feo G
    Boll Soc Ital Biol Sper; 1978 Nov; 54(21):2039-45. PubMed ID: 571724
    [No Abstract]   [Full Text] [Related]  

  • 54. Potential source of error in absorption rate calculations.
    Boxenbaum HG; Kaplan SA
    J Pharmacokinet Biopharm; 1975 Aug; 3(4):257-64. PubMed ID: 1185523
    [No Abstract]   [Full Text] [Related]  

  • 55. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intestinal absorption characteristics of ketoprofen in rats.
    Choi JS; Jin MJ; Han HK
    Biopharm Drug Dispos; 2006 Jan; 27(1):17-21. PubMed ID: 16278925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Physicochemical properties and intestinal absorption of a ground mixture of chloramphenicol palmitate with microcrystalline cellulose (author's transl].
    Yamamoto K; Matsuda S; Nakano M; Arita T; Nakai Y
    Yakugaku Zasshi; 1977 Apr; 97(4):367-72. PubMed ID: 559740
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of terephthalic acid upon the sulfadimethoxine content of blood plasma.
    Hoshi A; Yanai R; Kuretani K
    Chem Pharm Bull (Tokyo); 1967 Aug; 15(8):1138-44. PubMed ID: 5583169
    [No Abstract]   [Full Text] [Related]  

  • 59. Percutaneous absorption studies of chloramphenicol solutions.
    Aguiar AJ; Weiner MA
    J Pharm Sci; 1969 Feb; 58(2):210-5. PubMed ID: 5779863
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the relative measurement of the enteral resportion of drugs with the aid of pharmacokinetically determined serum level curves with the example of chloramphenicol].
    Betzien G; Vömel W
    Arzneimittelforschung; 1966 Aug; 16(8):1008-18. PubMed ID: 6014882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.